- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03209726
Assessment of S-ICD Eligibility With 12-Lead ECG (EL-SID)
February 25, 2021 updated by: Larisa Tereshchenko
Assessment of Subcutaneous Implantable Cardioverter Defibrillator Eligibility With 12-lead Electrocardiogram
The primary objective of this study is to develop an approach to determine eligibility for subcutaneous ICD by analyzing routine clinical 12-lead electrocardiogram.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
106
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Oregon
-
Portland, Oregon, United States, 97239
- Oregon Health and Science University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing ICD implantation for currently approved indications.
Description
Inclusion Criteria:
- medical condition, predisposing patient to life-threatening ventricular arrhythmias, eligible for currently approved ICD indications for primary or secondary prevention of sudden cardiac death
Exclusion Criteria:
- Acute medical condition (e.g. acute myocardial infarction, severe trauma, post-surgery, admitted to ICU)
- End stage organ failure
- Pregnancy
- Patient, legal guardian or authorized representative is unable or unwilling to cooperate or give written informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Amplitudes of R- and T-waves (and R/T ratios) on a special precordial ECG
Time Frame: at the day of ECG recording (cross-sectional study)
|
Amplitudes of R- and T-waves (and R/T ratios) on a special ECG (recorded for Subcutaneous ICD eligibility assessment)
|
at the day of ECG recording (cross-sectional study)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Thomas JA, Perez-Alday EA, Hamilton C, Kabir MM, Park EA, Tereshchenko LG. The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator. Comput Biol Med. 2018 Nov 1;102:242-250. doi: 10.1016/j.compbiomed.2018.05.002. Epub 2018 May 8.
- Wang L, Javadekar N, Rajagopalan A, Rogovoy NM, Haq KT, Broberg CS, Tereshchenko LG. Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease. Heart Rhythm. 2020 May;17(5 Pt B):860-869. doi: 10.1016/j.hrthm.2020.01.016.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 21, 2017
Primary Completion (Actual)
December 31, 2020
Study Completion (Actual)
December 31, 2020
Study Registration Dates
First Submitted
July 3, 2017
First Submitted That Met QC Criteria
July 3, 2017
First Posted (Actual)
July 6, 2017
Study Record Updates
Last Update Posted (Actual)
March 1, 2021
Last Update Submitted That Met QC Criteria
February 25, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00016034
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Implantable Defibrillator User
-
Paris Cardiovascular Research Center (Inserm U970)Hôpital Necker-Enfants MaladesCompletedImplantable Defibrillator User | Implantable Cardioverter Defibrillator Complications
-
Abbott Medical DevicesCompletedImplantable Defibrillator UserHungary, United States, Poland, Spain, United Kingdom
-
Biotronik, Inc.Terminated
-
Gulf Heart AssociationBoston Scientific Corporation; MedtronicCompletedImplantable Defibrillator UserUnited Arab Emirates
-
Beth Israel Deaconess Medical CenterUniversity of Colorado, Denver; Mayo Clinic; University of Pennsylvania; Emory... and other collaboratorsEnrolling by invitationImplantable Defibrillator UserUnited States
-
Universitätsklinikum KölnRecruitingImplantable Defibrillator User | Implantable Defibrillator Lead Dysfunction | Implantable Automatic Defibrillator MalfunctionGermany
-
Centre Hospitalier Universitaire de BesanconCompletedImplantable Defibrillator UserFrance
-
Susanne Schmidt PedersenOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsCompletedDistress | Implantable Defibrillator UserDenmark
-
Biotronik, Inc.University of RochesterActive, not recruitingCardiomyopathies | Implantable Defibrillator User | GenderUnited States